Baicalein is a novel TLR4-targeting therapeutics agent that inhibits TLR4/HIF-1α/VEGF signaling pathway in colorectal cancer

Minting Chen, Keying Zhong, Jincheng Tan, Mingjing Meng Meng, Chok Mei Liu, Baisen Chen, Chunhua Huang, Hoi Leong Xavier Wong, Zhaoxiang Bian, Tao Su*, Hiu Yee Kwan*

*Corresponding author for this work

Research output: Contribution to journalLetterpeer-review

Original languageEnglish
Article numbere564
JournalClinical and Translational Medicine
Issue number11
Publication statusPublished - Nov 2021

Cite this